Brain gene therapy tested for Parkinson's: safe?

NCT ID NCT05603312

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 21 times

Summary

This study tested a new gene therapy for Parkinson's disease. It involved 14 people and aimed to see if delivering a gene to a specific brain area is safe. The therapy uses a harmless virus to carry the gene. This is an early-stage trial focused on safety, not yet on effectiveness.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Columbia University Irving Medical Center

    New York, New York, 10032, United States

  • Henry Ford West Bloomfield Hospital

    West Bloomfield, Michigan, 48322, United States

  • Thomas Jefferson University

    Philadelphia, Pennsylvania, 19107, United States

  • Weill Cornell Medicine

    New York, New York, 10021, United States

  • West Virginia University

    Morgantown, West Virginia, 26506, United States

  • Yale University - Yale New Haven Hospital

    New Haven, Connecticut, 06510, United States

Conditions

Explore the condition pages connected to this study.